These findings suggest that epigenetic inactivation of FSTL1 short-cuts the paracrine secretion of FSTL1 by NPC cells, thus suppressing the inflammatory and anti-proliferative responses of innate immune cells in the cancer stroma. The gene discussed is FSTL1; the disease is cancer.